Article Details

Genting-backed biotech firm-Nasdaq co combination deadline extension sought

Retrieved on: 2021-04-18 05:30:21

Tags for this article:

Click the tags to see associated articles and topics

Genting-backed biotech firm-Nasdaq co combination deadline extension sought. View article details on hiswai:

Excerpt

KUALA LUMPUR (April 18): Genting Bhd's biotechnology arm Celularity Inc, which has entered into a definitive merger agreement with Nasdaq-listed ...

Article found on: www.theedgemarkets.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up